{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:09:56Z","timestamp":1792613396160,"version":"4.5.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0237005","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T17:43:14Z","timestamp":1597858994000},"page":"e0237005","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Health-related quality of life and fatigue in patients with chronic hepatitis C with therapy with direct-acting antivirals agents interferon-free"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2199-5978","authenticated-orcid":true,"given":"Ra\u00edssa Neves","family":"Fagundes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lincoln Eduardo Villela Vieira de Castro","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio Heleno de Lima","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,8,19]]},"reference":[{"issue":"8","key":"pone.0237005.ref001","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/jvh.12528","article-title":"Association of work productivity with clinical and patient-reported factors in patients infected with hepatitis C v\u00edrus","volume":"23","author":"ZM Younossi","year":"2016","journal-title":"Journal of Viral Hepatitis"},{"key":"pone.0237005.ref002","unstructured":"FDA. Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2009 28 September 2017; Available from: http:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/UCM193282.pdf."},{"issue":"3","key":"pone.0237005.ref003","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/hep.21565","article-title":"Kincaid, J. The effects of HCV infection and management on health-related quality of life","volume":"45","author":"ZM Younossi","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"pone.0237005.ref004","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11136-017-1710-6","article-title":"Presenting comparative study PRO results to clinicians and researchers: beyond the eye of the beholder","volume":"27","author":"M Brundage","year":"2018","journal-title":"Quality of Life Research"},{"issue":"10","key":"pone.0237005.ref005","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/apt.14604","article-title":"Safety and efficacy of ledipasvir\/sofosbuvir with or without ribavirin in hepatitis C genotype 1 patients including those with decompensated cirrhosis who failed prior treatment with simeprevir\/sofosbuvir","volume":"47","author":"AA Modi","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"pone.0237005.ref006","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1590\/S0080-623420150000600009","article-title":"Health-Related Quality of Life in patients with hepatitis C in double and triple therapy","volume":"49","author":"RN Fagundes","year":"2015","journal-title":"Revista da Escola de Enfermagem da USP"},{"issue":"4902","key":"pone.0237005.ref007","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA Clone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome","volume":"244","author":"Q Choo","year":"1989","journal-title":"Science"},{"issue":"6","key":"pone.0237005.ref008","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bpg.2008.11.002","article-title":"Chronic Viral Hepatitis as a Public Health Issue in the World","volume":"22","author":"D Lavanchy","year":"2008","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"pone.0237005.ref009","volume-title":"A Review of Viral Hepatitis and HIV Coinfection Among Injecting Drug Users and Assessment of Priorities for Future Activities","author":"N Walsh","year":"2009"},{"key":"pone.0237005.ref010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/apt.13090","article-title":"Alimentary Pharmacology and Therapeutics Systematic review: patient-reported outcomes in chronic hepatitis C\u2014the impact of liver disease and new treatment regimens","volume":"41","author":"Z Younossi","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"pone.0237005.ref011","unstructured":"CONITEC. Protocolo Cl\u00ednico e Diretrizes Terap\u00eautica para Hepatite C e Coinfec\u00e7\u00f5es. 2017. Minist\u00e9rio da Sa\u00fade do Brasil. http:\/\/conitec.gov.br\/images\/Consultas\/2017\/Relatorio_PCDT_HepatiteCeCoinfeccoes_CP11_2017.pdf. Acessado em 30 de abril de 2018."},{"issue":"3","key":"pone.0237005.ref012","first-page":"143","article-title":"Tradu\u00e7\u00e3o para a l\u00edngua portuguesa e valida\u00e7\u00e3o do question\u00e1rio gen\u00e9rico de avalia\u00e7\u00e3o de qualidade de vida SF-36 (Brasil SF-36)","volume":"39","author":"RM Ciconelli","year":"1999","journal-title":"Rev Bras Reumatol"},{"issue":"1","key":"pone.0237005.ref013","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1590\/S0102-311X2010000100021","article-title":"Cross-cultural adaptation of the Chronic Liver Disease Questionnaire (CLDQ) to the Brazilian population","volume":"26","author":"S Mucci","year":"2010","journal-title":"Cad. Sa\u00fade P\u00fablica"},{"issue":"4","key":"pone.0237005.ref014","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00520-009-0697-0","article-title":"Validation of the Portuguese Version of Functional Assessment of Cancer Therapy-Fatigue (FACT-F) in Brazilian Cancer Patients","volume":"18","author":"NM Ishikawa","year":"2010","journal-title":"Support Care Cancer"},{"issue":"7","key":"pone.0237005.ref015","first-page":"604","article-title":"The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: validation of version 4 of the core questionnaire","volume":"8","author":"K Webster","year":"1999","journal-title":"Qual Life Research"},{"issue":"149","key":"pone.0237005.ref016","first-page":"1","article-title":"Mental and physical health-related quality of life in patients with hepatitis C is related to baseline comorbidities and improves only marginally with hepatitis C cure","volume":"9","author":"PJ Thuluvath","year":"2018","journal-title":"Clinical and Translational Gastroenterology"},{"issue":"4","key":"pone.0237005.ref017","doi-asserted-by":"crossref","first-page":"440","DOI":"10.5009\/gnl17322","article-title":"Factors Associated with Health-Related Quality of Life in Korean Patients with Chronic Hepatitis C Infection Using the SF-36 and EQ-5D","volume":"12","author":"ES Jang","year":"2018","journal-title":"Gut na Liver"},{"issue":"11","key":"pone.0237005.ref018","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/jvh.12554","article-title":"Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus","volume":"23","author":"ZM Younossi","year":"2016","journal-title":"J Viral Hepat"},{"issue":"7","key":"pone.0237005.ref019","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1097\/MD.0000000000005914","article-title":"Superiority of Interferon-Free Regimens for Chronic Hepatitis C: The Effect on Health-Related Quality of Life and Work Productivity","volume":"96","author":"ZM Younossi","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"pone.0237005.ref020","first-page":"516","article-title":"Adherence to treatment and quality of life during hepatitis C terapy: a prospective, real life, observational study","volume":"31","author":"P Marcellin","journal-title":"Liver International. 2011"},{"issue":"2","key":"pone.0237005.ref021","doi-asserted-by":"crossref","first-page":"50","DOI":"10.24171\/j.phrp.2018.9.2.03","article-title":"Treatment with Sofosbuvir and Daclatasvir (with or without Ribavirin) Improves Patient Reported Outcomes in Hepatitis C","volume":"9","author":"LPJ Medeiros","year":"2018","journal-title":"Osong Public Health and Research Perspectives"},{"issue":"10","key":"pone.0237005.ref022","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jval.2018.01.006","article-title":"French Patients with Hepatitis C Treated with Direct-Acting Antiviral Combinations: The Effect on Patient-Reported Outcomes","volume":"21","author":"P Cacoub","year":"2018","journal-title":"Value in Health"},{"issue":"6","key":"pone.0237005.ref023","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/hep.27161","article-title":"Patient-reported outcomes in chronic hepatites C patients with cirrhosis treated with sofosbuvir containing regimens","volume":"59","author":"ZM Younossi","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"pone.0237005.ref024","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.cld.2017.03.011","article-title":"Patient-Reported Outcomes and Fatigue in Patients with Chronic Hepatitis C Infection","volume":"21","author":"P Golabi","journal-title":"Clin Liver Dis. 2017"},{"issue":"5","key":"pone.0237005.ref025","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/liv.14014","article-title":"Early HCV Viral Kinetics Under DAAs May Optimize Duration of Therapy in Patients With Compensated Cirrhosis","volume":"39","author":"M Gambalto","year":"2019","journal-title":"Liver Int"},{"issue":"3","key":"pone.0237005.ref026","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/jvh.12483","article-title":"Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries","volume":"23","author":"ZM Younossi","year":"2016","journal-title":"Journal of Viral Hepatitis"},{"issue":"10","key":"pone.0237005.ref027","first-page":"0205277","article-title":"Impact of successful treatment with direct- acting antiviral agents on health-related quality of life in chronic hepatitis C patients","volume":"13","author":"R Juanbeltz","year":"2018","journal-title":"Hepatology International"},{"key":"pone.0237005.ref028","unstructured":"CONITEC. Protocolo Cl\u00ednico e Diretrizes Terap\u00eautica para Hepatite C e Coinfec\u00e7\u00f5es. (2019). Minist\u00e9rio da Sa\u00fade do Brasil. http:\/\/www.aids.gov.br\/pt-br\/pub\/2017\/protocolo-clinico-e-diretrizes-terapeuticas-para-hepatite-c-e-coinfeccoes. Acessado em 30 de mar\u00e7o de 2019."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0237005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T17:43:47Z","timestamp":1597859027000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0237005"}},"subtitle":[],"editor":[{"given":"Yury E.","family":"Khudyakov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,19]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0237005","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,19]]}}}